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ABSTRACT
Microsatellite instability (MSI) is associated with
defective DNA mismatch repair in various human
malignancies. Using a unique fluorescent technique,
we have observed two distinct modes of dinucleotide
microsatellitealterations inhumancolorectalcancer.
Type A alterations are defined as length changes of
<6 bp. Type B changes are more drastic and involve
modifications of >8 bp. We show here that defective
mismatchrepairisnecessaryandsufficientforTypeA
changes. These changes were observed in cell lines
and in tumours from mismatch repair gene-knockout
mice. No Type B instability was seen in these cells or
tumours. In a panel of human colorectal tumours,
bothTypeAMSIandTypeBinstabilitywereobserved.
Both types of MSI were associated with hMSH2
or hMLH1 mismatch repair gene alterations. Intrigu-
ingly, p53 mutations, which are generally regarded
as uncommon in human tumours of the MSI
1 pheno-
type, were frequently associated with Type A
instability, whereas none was found in tumours
with Type B instability, reflecting the prevailing view-
point. Inspection of published data reveals that the
microsatellite instability that has been observed in
various malignancies, including those associated
with Hereditary Non-Polyposis Colorectal Cancer
(HNPCC),ispredominantlyTypeB.Ourfindingsindic-
atethatTypeBinstabilityisnotasimplereflectionofa
repair defect. We suggest that there are at least two
qualitatively distinct modes of dinucleotide MSI in
humancolorectalcancer,andthatdifferentmolecular
mechanisms may underlie these modes of MSI. The
relationship between MSI and defective mismatch
repairmay bemorecomplexthan hithertosuspected.
INTRODUCTION
Microsatellites are repetitive DNA sequences comprising
short reiterated motifs dispersed throughout the eukaryotic
genome (1). Microsatellite lengths are highly polymorphic
in human populations, but appear stable during the life
span of the individual. Somatic instability of microsatellite
sequences has initially been reported in human colorectal
cancer (2,3), and particularly in the familial cancer-prone syn-
drome, hereditary non-polyposis colorectal cancer (HNPCC)
(4,5). In 1993, mutations in one of the genes encoding proteins
essential for DNA mismatch repair (MMR) were found in
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doi:10.1093/nar/gki303HNPCC individuals (6,7). MMR is an important editing
system. It counteracts the base mismatches and strand mis-
alignments that occur during DNA replication and recombina-
tion (8). Repetitive sequences such as those comprising
microsatellites are particularly prone to polymerase slippage
and, consequently, strand misalignment. If these errors remain
uncorrected, the mutations are ﬁxed during subsequent rep-
lication as addition or deletion of one (or more) repeat units.
The phenomenon of unstable microsatellites, i.e. microsatel-
lite instability (MSI), in which tumour cells accumulate this
type of repeat length alterations in microsatellites, is con-
sidered to reﬂect MMR deﬁciency. The MSI
+ phenotype is
frequently associated with various human malignancies (9).
As defective MMR is regarded as a risk factor for familial
predisposition or second malignancies, analyses of microsatel-
lite instability have been prevalent, particularly in the ﬁeld of
oncology. However, the reported frequency for MSI
+ tumours
in each malignancy differs widely in the literature (9).
Although analysis of MSI is now commonplace, a designa-
tion of MSI
+ may sometimes be a difﬁcult decision. The 1997
National Cancer Institute (NCI) workshop, ‘Microsatellite
Instability and RER Phenotypes in Cancer Detection and
Familial Predisposition’, suggested that the variety of micro-
satellites used was a major cause of discrepancies among data
from various laboratories, and recommended a panel of ﬁve
microsatellites as ‘working reference panel’ (10). We believe
that, in addition to selection of targets for analysis, methodo-
logical problems also account for some of the variability in
results. Changes in microsatellite lengths are sometimes
minor—as small as loss or gain of a single repeat unit. In addi-
tion, cells carrying changes in microsatellite sequences are not
always major in a given sample. However, in an assay system
using the conventional sequencing gel electrophoresis and
autoradiography, it appears difﬁcult to resolve microsatellite
PCR products precisely and quantitatively. PCR itself has an
intrinsic variability. The most widely used thermostable DNA
polymerase (Taq) has a terminal deoxynucleotidyl transferase
(TDT)activity,whichaddsoneadditionalbasetoPCRproducts
in a sequence-dependent manner. TDT activity of Taq poly-
meraseisvariablyexpressed,dependingontheconditionsused.
This property, in addition to intrinsic strand misalignment
during ampliﬁcation of microsatellite repeats, increases the
complexityofPCRproducts.Intheconventionalmicrosatellite
analysis, intrinsic caution and the desire to avoid scoring false-
positives may have led to an underestimate of the frequency of
minor,moresubtlemicrosatellitechanges,suchasalterationsof
limited numbers of repeat units. We have applied our ﬂuore-
scent technique for microsatellite instability analysis (11) to
address these problems. Here, we report that relatively subtle
alterations in microsatellites are indeed generally associated
with MMR deﬁciency. In contrast, most HNPCC tumours dis-
playmuchmoreextensivemicrosatellitechanges.Ourﬁndings
suggest that there are previously unrecognized aspects of
microsatellite instability in human cancer.
MATERIALS AND METHODS
Cells and tissue specimens
Msh2
 /  mouse embryonic ﬁbroblast (MEF) cell line,
RH95021 (12) and Mlh1
 /  MEF cell line, MC2, were kindly
provided by Dr Hein te Riele, Amsterdam Cancer Center and
Dr Michael Liskay, University of Oregon, respectively. Cells
were cultured in DMEM supplemented with 10% fetal calf
serum, penicillin (100 U/ml) and streptomycin (100 mg/ml).
Samples of cancer tissues and the corresponding normal
mucosa were obtained from 79 patients with colorectal car-
cinoma who underwent surgery in the Department of Surgery
and Science, Kyushu University Hospital from 1996 to 1999.
Written informed consent for studies using the tissues was
obtained from each patient. Ethical approval was obtained
from the IRB of Kyushu University. Specimens, taken imme-
diately after resection, were placed in liquid nitrogen. High
molecular weight DNA was extracted and subjected to micro-
satellite analyses.
Microsatellite instability
Microsatelliteanalysisusingﬂuorescence-labelledprimersand
anautomatedDNAsequencerhasbeendescribedindetail(11).
Brieﬂy, ﬁve human dinucleotide microsatellites, D2S123,
D5S107, D10S197, D11S904 and D13S175, in genomic
DNA from tissue specimens were ampliﬁed by PCR. 50
primers were labelled with the ﬂuorescent compound, ROX
(6-carboxy-x-rhodamine) or HEX (6-carboxy-20,40,70,4,
7,-hexachloro-ﬂuorescein). PCR reactions were done using
TaKaRa Taq (TaKaRa Co. Ltd., Tokyo, Japan). T4 DNA
polymerase was added to the PCR products, followed by
incubation at 37 C for 10 min. To compare electrophoretic
proﬁles between two samples, 1.2 ml of ROX-labelled product
and 0.3 mlofHEX-labelledproductweremixed. Samples were
denatured and loaded onto the ABI 373A sequencer (Applied
Biosystems, Foster City, CA, USA). The data were processed
using the GeneScan software (Applied Biosystems). For mice,
three dinucleotide microsatellites, D1Mit62, D6Mit59 and
D7Mit91, were analysed.
DNA sequencing
All the exons and exon–intron junctions of hMSH2 and
hMLH1 were ampliﬁed by PCR using Taq polymerase with
30 exonuclease activity, TaKaRa Ex Taq (TaKaRa Co. Ltd.,
Tokyo, Japan). Primer sequences are the same as reported by
Kolodner et al. (13,14), except that the additional sequence
complementary forM13universalprimerwasdeleted,andthat
one-step PCR was mainly employed. PCR products were used
as a template for cycle sequencing reactions using BigDye
terminator cycle sequencing kit (Applied Biosystems, Foster
City, CA, USA). Mutations found in one PCR product were
veriﬁed by reverse sequencing and ﬁnally conﬁrmed in two
independently ampliﬁed PCR products. Sequencing analyses
of p53 gene (exon 5–9) were performed using p53 primers
(Nippon Gene, Tokyo, Japan).
Immunohistochemistry
Tissue specimens were ﬁxed in buffered 10% paraformalde-
hyde and embedded in parafﬁn. Prior to the assay, the
specimens were sectioned at 4 mm and deparafﬁnized using
xylene. Immunohistochemistry was performed using the
streptavidin–biotin–peroxidase complex method (Histoﬁne
SAB kit, Nichirei, Tokyo, Japan) using an automated stainer
(VENTANA Discovery System, Ventana Medical Systems
Inc., Tucson, AZ, USA). At least, two independent antibodies
Nucleic Acids Research, 2005, Vol. 33, No. 5 1629were used to conﬁrm the status of negative staining. Sections
prepared from Msh2- and Mlh1-knockout mice were also
used as negative controls. Antibodies used were as follows:
anti-MSH2; NA27 and NA26 (Oncogene Research Products,
Cambridge, MA, USA), anti-MLH1; PM-13291A (Phar
Mingen, Hamburg, Germany), NA28 (Oncogene Research
Products) and sc-581 (Santa Cruz Biotechnology Inc., Santa
Cruz, CA, USA).
RESULTS
Two modes of dinucleotide microsatellite instability
in human cancer
We have established a sensitive ﬂuorescent technique for
microsatellite analysis (11). Application of this technique to
human cancers revealed a number of previously unrecognized
aspectsofMSI.Inparticular,we observed twodistinct patterns
of alterations at dinucleotide microsatellites in human malig-
nancies (15–17). Examples are shown in Figure 1. In some
cases, length changes are relatively small and affect <6b p
(Type A, Figure 1A–D). In the other, more dramatic changes
involving >8 bp are observed (Type B) (Figure 1E–H).
Because Type B alterations involve large differences in micro-
satellite length, it can sometimes appear as if a ‘third’ allele is
present in addition to the parental alleles (Figure 1E–H).
Throughout the analyses using this technique, results were
highly reproducible in several independent experiments.
Neither additional peaks nor changes in the ratio between
peaks were noted.
Microsatellite instability observed in mismatch repair
gene-knockout mice
To analyse MSI in a deﬁned genetic background, we used
the Msh2
 /  MEF cell line RH95021 (12). Alterations in the
lengths of three dinucleotide microsatellites were analysed
in RH95021 subclones. The majority of subclones (14/21)
exhibited the same conﬁguration at the D6Mit59 locus
(exempliﬁed by clone a, Figure 2A). In clones that deviated
from this predominant pattern (Figure 2A, clones b–d), the
microsatellite length was altered by <4 bp. In other words,
the microsatellite changes were invariably Type A. A similar
pattern of small-scale microsatellite changes was observed at
Figure 1. Type A and Type B microsatellite instability observed in human colorectal cancer. Using genomic DNA samples prepared from cancer and the
corresponding normal mucosa, microsatellite sequences, indicated at the right top of each panel, were amplified by PCR with primers differentially labelled
with fluorescence, then mixed and run on a same lane in an automated DNA sequencer. The amount of each DNA fragment was quantitatively detected and its size
was estimated with accuracy of 1 bp, by standardization with size markers run in each lane. Results representative for each mode of microsatellite instability are
shown:redlines,cancer;greenlines,normalmucosa;TypeA,(A)(IC678),(B)(IC810),(C)(IC721)and(D)(IC793);TypeB,(E)(IC790),(F)(IC733),(G)(IC690)
and (H) (NoTa). Patient codes in the parentheses correspond to those used in Table 1.
1630 Nucleic Acids Research, 2005, Vol. 33, No. 5Figure2. MicrosatellitechangesinMsh2
 / mouseembryonicfibroblast(MEF)cellsandintumoursthataroseinMsh2-knockoutmice.(A)Morethan20subclones
wereisolatedfromRH95021(Msh2
 / )MEFcellsandmicrosatellitechangeswerecomparedamongthesesubclones.Themajorityexhibitedthesameconfiguration
(clone a) and a few deviated from this predominant pattern (clone b–d). In each clone, the pattern of clone A has been superimposed with green lines, to facilitate
comparison. Results obtained in D6Mit59 microsatellite are shown. (B) RH95021 cells were continuously cultured and sampled at different passages. Results
obtained in D6Mit59 microsatellite at passage 1, 20, 30 and 81 are shown. In passage 81, the initial profile at passage 1 has been superimposed with a green line.
(C)TumoursthataroseinvivoinMsh2-knockoutmicewereanalysed.RepresentativeresultsobtainedinD7Mit91(tumoursaandb)andD6Mit59(tumourscandd)
microsatellites are shown: red lines, tumour; green lines, the corresponding normal tissue.
Table 1. hMSH2 and hMLH1 alterations found in tumours exhibiting Type A and Type B MSI
MSI      NUCLEAR    SEQUENCE SUMMARY
A/B   EXPRESSION exon hMSH2 exon hMLH1
PATIENT hMSH2 hMLH1 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19
IC669 APN cytoplasmic hMLH1
IC678 AP P L521I (CTC to ATC)
IC692 AP P G132G (GGC to GGA)
IC721 AP P L390F (CTT to TTT)
IC724 AP P G178R (GGA to AGA)
IC759 AP P
IC793 APN hMLH1  silencing
IC807 AP P I219V (ATC to GTC)
IC810 AP P hMSH2 ; L390F  / hMLH1 ; I219V
IC815 AP P
IC824 AP P
IC860 AP P
IC622 B PP
IC653 B PP
IC676 B PP
IC690 B P N R226Q (CGA to CAA)  / cytoplasmic hMLH1, HNPCC
IC698 B PP I219V (ATC to GTC)
IC733 B PP
IC790 B PP
IC853 B PP G132G (GGC to GGA)
IC873 B PP Q604Q (CAA to CAG)
NoTa B P* N* hMLH1  silencing, HNPCC
MSI,microsatelliteinstability;P,positivenuclearstaininginimmunohistochemistry;N,negative;*,determinedbyimmunoblotting;Closedcircle,basesubstitution
with amino acid change; open triangle, possible polymorphism; Open rectangle, base substitution without amino acid change.
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(data not shown). To investigate whether Type B variations
might simply reﬂect the accumulation of numerous smaller
alterations over many generations, RH95021 cells were con-
tinuously cultured, and sampled periodically at different
passages. As shown in Figure 2B, even after undergoing 81
population doublings (2
81 corresponds to 10
24), there was no
detectable appearance of shorter or longer D6Mit59 alleles.
Similar patterns were observed at the two other microsatellite
loci (data not shown). Thus, there was no evidence of the
accumulation of changes consistent with Type B instability
at any of the three microsatellites in these MMR-defective
MEFs. Similar data were obtained using a second MMR-
deﬁcient MEF cell line, MC2, which derived from an
Mlh1
 /  mouse (data not shown).
We also examined microsatellite instability in lymphomas
and adenocarcinomas that arose in various organs of
Msh2
 / mice. Among 16 tumours that were analysed at the
three microsatellite loci, each contained alterations at one
or more locus. In all cases, changes were limited to <6
bp (examples are shown in Figure 2C) and no Type B altera-
tion was observed. Intriguingly, an examination of published
microsatellite changes in cells of MMR gene-knockout mice
clearly indicates that most changes are of Type A (12,18,19).
Analysis of microsatellites in MEFs and tumours from
MMR-defective animals therefore indicates that Type A
MSI is a direct consequence of defective MMR. The absence
of more extensive microsatellite length changes may indicate
further that an Msh2 or Mlh1 defect is insufﬁcient for the
development of Type B instability.
Mismatch repair gene inactivation is associated
with both Type A and Type B MSI in human
colorectal cancer
HNPCC patients inherit mutations in MMR genes (6,7). More
than 90% of HNPCC tumours are MSI
+ (20). The MSI
+ pheno-
type is also frequent among sporadic colorectal carcinomas
(2–4,6,21). Inspection of published data derived from the con-
ventional microsatellite analysis reveals that microsatellite
changes thus far reported in various tumours, including those
in HNPCC individuals, are largely Type B (2–4,20–22).
We considered the possibility that the more subtle Type A
MSImight have remained undetected insome cases. Usingour
ﬂuorescent assay with a panel of ﬁve dinucleotide repeat
microsatellites, we found that the frequencies of Type A
and Type B MSI among 79 colorectal carcinomas were 30%
and 17%, respectively. In agreement with previous observa-
tions that Type B instability is common in HNPCC colon
tumours, the IC690 tumour and the colorectal carcinoma
cell line, NoTa (Table 1), both of which were derived from
patients who fulﬁlled the Amsterdam Criteria II for HNPCC
(23), exhibited Type B instability (Figure 1G and H). Our
ﬁnding that 17% of colorectal tumours display Type B MSI
is consistent with the generally reported ﬁgure of around 20%
for MSI among colorectal carcinomas (20,24,25). The obser-
vation that a further 30% of tumours displayed Type A MSI
suggests that the frequency of MSI, at least in colorectal car-
cinomas, has previously been underestimated.
The relationship between MSI and defective MMR in our
set of colorectal tumours was investigated further. hMSH2 and
hMLH1 MMR genes of 12 tumours with Type A and 9 with
Type B MSI were sequenced. The same genes in the NoTa cell
line were also sequenced (Figure 3A and Table 1). Sequence
alterations causing amino acid substitutions were identiﬁed
in 5 of the 21 tumours. Four of these (80%) were associated
with Type A MSI. In addition, one patient with Type A MSI
(IC793) in whom no mutation was identiﬁed was negative for
immunohistochemical staining of hMLH1 (Figure 3B, panel
b). This is consistent with a possible epigenetic hMLH1 gene
silencing (26–28). In one other Type A case (IC669) and one
Type B case (IC690), there was an abnormal intracellular
distribution of hMLH1 which remained predominantly cyto-
plasmic (Figure 3B, panels c and d). Among the 10 tumours
displaying Type B MSI, there was an example of base sub-
stitutions causing amino acid change in hMLH1. In this case,
IC690, the failure of hMLH1 to localize to the nucleus was
associated with the codon 226 mutation in exon 8 (Figure 3A,
Figure 3. hMSH2 and hMLH1 alterations in tumours exhibiting Type A or
Type B microsatellite instability. (A) Sequences for all the exons including
exon–intron boundaries of hMSH2 and hMLH1 were determined using an
automated sequencer. Sequence alterations found at (a) codon 390 of hMSH2
(patient IC810), (b) codon 219 of hMLH1 (patient IC810) and (c) codon 226
of hMLH1 (patient IC690) were shown. (B) Abnormal expression of hMLH1
proteinsobservedinapanelofhumancolorectalcarcinomas.(Panela)Atypical
result with a strong nuclear staining implying normal hMLH1 expression
(IC853). (Panel b) Complete loss of hMLH1 expression in tumour cells, which
suggest a possible epigenetic silencing (IC793). (Panels c and d) Results with-
out evident nuclear staining, but with an accumulation of hMLH1 antigens in
the tumour cytoplasm, which may suggest an abnormal intracellular distribu-
tion of this protein (IC690 and IC669).
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as Type B, is indeed associated with MMR defects.
p53 mutation is strongly associated with Type A
MSI in human colorectal cancer
One view of the involvement of MMR defects in cancer devel-
opment is that the ‘microsatellite mutator phenotype (MMP)’
(29,30) in mismatch repair-defective cells offers an alternative
to chromosomal instability as a mechanism for genetic instab-
ility in cancer (31). On this model, MSI and chromosomal
instability represent mutually exclusive pathways of tumour
development. This reasoning is based partly in the observation
that p53 mutations, commonly associated with chromosomal
instability, are infrequent among MSI
+ tumours (2,32–34). To
examine the relationship between Type A/B instability and
p53 mutation, we sequenced the p53 gene in our panel of
79 colorectal tumours. p53 mutations resulting in an amino
acid substitution were detected in 23 tumours (29.1%). The
mutations were predominantly transitions in acknowledged
hot spots; codons 175, 248 and 273 (Table 2). Of the p53
mutations that were found in MSI
+ tumours, all were associ-
ated with Type A MSI (Tables 2 and 3). No p53 mutations
were detected among the 14 Type B tumours. Among Type A
tumours, the frequency of p53 mutation approached 50%
(12/25). These ﬁndings conﬁrm that p53 mutations are rare
in tumours with Type B MSI. More importantly, they suggest
that, in contrast to prevailing opinion, defective MMR is sig-
niﬁcantly associated with p53 mutation, at least in human
colorectal cancer.
DISCUSSION
The ﬂuorescent technique we used here allows the unequi-
vocaldesignationofTypeAandTypeBMSI,andhasrevealed
a previously unrecognized complexity in the relationship
between dinucleotide MSI and defective DNA MMR in
human cancer. Type A MSI (changes < 6 bp) is clearly linked
with MMR inactivation in both mice and humans, which
implies that Type A MSI is a direct consequence of defective
MMR. Since we found no evidence of Type B instability
(changes > 8 bp) in MMR-defective animals, it is possible
that changes in addition to repair deﬁciency contribute to, or
are responsible for, Type B MSI. One important ﬁnding of this
study is that Type A instability is frequent among human
tumours. Type A MSI predominated in our large panel of
colorectal carcinomas. We suggest that, because the changes
associated with Type A instability are more subtle, the fre-
quency of MSI among colorectal tumours may have been
considerably underestimated. Our ﬁndings also reveal a hith-
erto unrecognized association between defective MMR and
p53 mutation. Signiﬁcantly, Type A MSI was strongly asso-
ciated with p53 mutation in human colorectal tumours. Since
Type A instability is unequivocally associated with MMR
deﬁciency, this novel ﬁnding implies that, in contrast to
prevailing opinion, p53 mutations are common in MMR-
defective tumours, at least in human colorectal cancer.
Established guidelines for classiﬁcation of MSI utilize
the frequency of changes in a deﬁned set of microsatellite
Table 2. p53 mutations found in 79 colorectal carcinomas
No. Patient EX05 EX06 EX07 EX08 EX09 Codon change Base substitution (type) AA change MSI
1 IC628 273 CGT ! CAT G:C ! A:T TS Arg ! His N
2 IC630 196 CGA ! TGA G:C ! A:T TS Arg ! stop A
3 IC634 306 CGA ! TGA G:C ! A:T TS Arg ! stop N
4 IC668 193 CAT ! CGT A:T ! G:C TS His ! Arg N
5 IC669 175 CGC ! CAC G:C ! A:T TS Arg ! His A
6 IC673 176 TGC ! AGC A:T ! T:A TV Cys ! Ser N
7 IC674 285 GAG ! AAG G:C ! A:T TS Glu ! Lys N
8 IC680 ND 255 ATC ! ACC A:T ! G:C TS Ile ! Thr A
9 IC693 179 CAT ! CTT A:T ! T:A TV His ! Leu A
10 IC694 273 CGT ! CAT G:C ! A:T TS Arg ! His A
11 IC711 239 AAC ! GAC A:T ! G:C TS Asn ! Asp N
12 IC721 175 CGC ! CAC G:C ! A:T TS Arg ! His A
13 IC748 190 ND CCT ! CTT G:C ! A:T TS Pro ! Leu A
14 IC754 196 CGA ! CCA G:C ! C:G TV Arg ! Pro N
15 IC763 151 CCC ! CAC G:C ! T:A TV Pro ! His N
16 IC772 175 CGC ! CAC G:C ! A:T TS Arg ! His A
17 IC778 175 ND CGC ! CAC G:C ! A:T TS Arg ! His N
18 IC784 214 ND ND CAT ! CGT A:T ! G:C TS His ! Arg A
19 IC808 205 TAT ! GAT A:T ! C:G TV Tyr ! Asp A
20 IC812 190 CCT ! CTT G:C ! A:T TS Pro ! Leu N
21 IC816 273 CGT ! CAT G:C ! A:T TS Arg ! His A
22 IC819 248 CGG ! CAG G:C ! A:T TS Arg !Gln N
23 IC860 273 CGT ! CAT G:C ! A:T TS Arg ! His A
MSI, microsatellite instability;N, negative; A, Type A MSI; TS, transition; TV, transversion;ND, not determined.Bold codon numbersindicate the acknowledged
hot-spots for mutation.
Table 3. p53 mutation highly correlates with Type A MSI
MSI Subtotal
Type A Type B Negative
Wild type 13 14 29 56
p53
Mutant 12 0 11 23
Subtotal 25 14 40 79
p = 0.006. MSI: Microsatellite instability.
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differences in microsatellite changes are not widely discussed.
In one of the earliest report of the MSI phenomenon, however,
Thibodeau et al. divided microsatellite changes into two cat-
egories; Type I and II mutations (3). The former was deﬁned a
‘signiﬁcant increase (expansion) or decrease (deletion) in the
apparent fragment size’ and the latter asa ‘single 2bp change’.
This distinction has received little attention since then. Our
data indicate that Type A MSI, which appears similar to their
TypeII mutation,ismore frequent than hitherto suspected, and
suggest that it represents the bona ﬁde MMR-deﬁcient pheno-
type. On the other hand, Type I mutations may correspond to
our Type B instability. The problem is that mutations in MMR
genes have been reported in tumours displaying this type of
instability. More than 90% of HNPCC tumours are MSI
+ (20),
and this type of MSI can be categorized as Type B/Type I
(2–4,20–22). However, the frequencies of mutation in the two
major MMR genes, hMSH2 and hMLH1, in HNPCC kindred
are not high in some reports (35–40). Among the panel of
tumours displaying Type B MSI, we found a base substitution
mutation in hMLH1 and one case with a possible hMLH1
silencing. This incidence of MMR gene inactivation in the
Type B group is not unduly low, compared with the reported
frequencies in the literature (25,36,41–43). The relationship
between Type B MSI and defective MMR is probably more
complex than hitherto suspected.
Type B MSI may involve molecular abnormalities in addi-
tion to defective MMR. We suggest that whereas Type A MSI
probably reﬂects the uncorrected DNA polymerase slippage
events that accumulate in MMR-defective cells, inappropriate
processing of damage by recombinational DNA repair may
contribute to Type B MSI. This hypothesis may be supported
partly by our observation that there was no evidence of the
emergence of Type B instability in MMR gene-knockout
animals. It is known that microsatellite alterations occur via
several independent mechanisms, including recombination
(44–46), and MMR counteracts incorrect strand alignment
during homologous recombination (47). The drastic micro-
satellite changes in Type B MSI may be more consistent
with dynamic events, such as recombination, than with rep-
lication slippage. In this context, defective MMR might be a
promoting, and consequently highly coincidental, but insufﬁ-
cient factor for Type B changes. Connection between MSI and
the recombinational repair pathway in tumours, particularly in
HNPCC, may warrant attention.
Type AMSIis also strongly associated with p53 mutation in
human colorectal tumours. This observation may be compat-
ible with several recent reports (36,48,49) that have shown a
connection between p53 mutation and the MSI-L phenotype,
since in colorectal cancer Type A MSI tends to be observed in
a limited number of markers and, consequently, categorized
as MSI-L. This ﬁnding may also provide an insight to
the mechanism of genetic instability in tumours. Genetic
instability in tumours has been regarded as deriving from
two mutually exclusive pathways, chromosomal instability
(CIN)—frequently associated with mutations in various onco-
genes or tumour suppressor genes such as p53—and ‘micro-
satellite mutator phenotype (MMP)’ (29,30), in which p53
mutations are rare and, instead, mutations are found in mono-
nucleotide repeats within genes of a different variety. Several
recentreportssuggestthattheremightbean oversimpliﬁcation
inthisdistinction(50–53).Fromourobservations,dinucleotide
MSI in tumours can be divided into two modes, Type A and
Type B, and Type A instability is the direct consequence of
defective MMR. A close association of Type A MSI with p53
mutation may suggest a hitherto unrecognized causal relation-
ship between p53 mutation and defective MMR. p53 muta-
tions may derive from a state with an elevated mutation rate,
i.e. MMR-deﬁcient phenotype, as initially suspected. Thus,
our observations suggest added complexities to the relation-
ship between MMR defects and MSI, and also shed light
on previously unrecognized fundamental processes in the
molecular mechanisms of genetic instability underlying
tumour development.
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